Physician profile
Lee Schmitt
NPI 1437103801
$3,279.83
in general payments reported to CMS, 2019-2025
9 companies · $408 in 2025
The $408 reported for 2025 was more than what 75% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $212 · 2020: $32.60 · 2021: $126 · 2022: $337 · 2023: $1,106 · 2024: $1,059 · 2025: $408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,557 · Travel and Lodging: $986 · Education: $29.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,557.30 |
| Travel and Lodging | $986.20 |
| Education | $29.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,714.56 | 2021-2025 | Ligasure, Signia, Sonicision |
| Ethicon US, LLC | $190.88 | 2019-2023 | Echelon Flex |
| Covidien LP | $138.83 | 2019 | |
| Conmed Corporation | $106.09 | 2023-2024 | Airseal |
| Endo Pharmaceuticals INC. | $43.51 | 2019 | |
| Standard Bariatrics, INC. | $39.09 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $20.16 | 2021 | |
| Novo Nordisk INC | $16.94 | 2023 | Wegovy |
| Intuitive Surgical, INC. | $9.77 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Schmitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.